Wu G - Search Results

1

N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives.

Xu Z, Peng B, Cai Y, Wu G, Huang J, Gao M, Guo G, Zeng S, Gong Z, Yan Y. Xu Z, et al. Among authors: wu g. Biochem Pharmacol. 2020 Dec;182:114258. doi: 10.1016/j.bcp.2020.114258. Epub 2020 Oct 2. Biochem Pharmacol. 2020. PMID: 33017575 Review.

2

A tropomyosin receptor kinase family protein, NTRK2 is a potential predictive biomarker for lung adenocarcinoma.

Wang X, Xu Z, Chen X, Ren X, Wei J, Zhou S, Yang X, Zeng S, Qian L, Wu G, Gong Z, Yan Y. Wang X, et al. Among authors: wu g. PeerJ. 2019 Jun 17;7:e7125. doi: 10.7717/peerj.7125. eCollection 2019. PeerJ. 2019. PMID: 31245181 Free PMC article.

3

CFHR1 is a potentially downregulated gene in lung adenocarcinoma.

Wu G, Yan Y, Wang X, Ren X, Chen X, Zeng S, Wei J, Qian L, Yang X, Ou C, Lin W, Gong Z, Zhou J, Xu Z. Wu G, et al. Mol Med Rep. 2019 Oct;20(4):3642-3648. doi: 10.3892/mmr.2019.10644. Epub 2019 Sep 3. Mol Med Rep. 2019. PMID: 31485643 Free PMC article.

4

Expression and clinical significance of CPS1 in glioblastoma multiforme.

Wu G, Yan Y, Zhou Y, Wang X, Wei J, Chen X, Lin W, Ou C, Zhou J, Xu Z. Wu G, et al. Curr Res Transl Med. 2019 Nov;67(4):123-128. doi: 10.1016/j.retram.2019.08.003. Epub 2019 Sep 3. Curr Res Transl Med. 2019. PMID: 31492588

5

Sulforaphane: Expected to Become a Novel Antitumor Compound.

Wu G, Yan Y, Zhou Y, Duan Y, Zeng S, Wang X, Lin W, Ou C, Zhou J, Xu Z. Wu G, et al. Oncol Res. 2020 Sep 1;28(4):439-446. doi: 10.3727/096504020X15828892654385. Epub 2020 Feb 28. Oncol Res. 2020. PMID: 32111265 Free PMC article. Review.

6

CPS1 expression and its prognostic significance in lung adenocarcinoma.

Wu G, Zhao Z, Yan Y, Zhou Y, Wei J, Chen X, Lin W, Ou C, Li J, Wang X, Xiong K, Zhou J, Xu Z. Wu G, et al. Ann Transl Med. 2020 Mar;8(6):341. doi: 10.21037/atm.2020.02.146. Ann Transl Med. 2020. PMID: 32355785 Free PMC article.

7

The novel roles of virus infection-associated gene CDKN1A in chemoresistance and immune infiltration of glioblastoma.

Hu K, Li J, Wu G, Zhou L, Wang X, Yan Y, Xu Z. Hu K, et al. Among authors: wu g. Aging (Albany NY). 2021 Feb 17;13(5):6662-6680. doi: 10.18632/aging.202519. Epub 2021 Feb 17. Aging (Albany NY). 2021. PMID: 33621203 Free PMC article.

8

Expression and molecular profiles of the AlkB family in ovarian serous carcinoma.

Cai Y, Wu G, Peng B, Li J, Zeng S, Yan Y, Xu Z. Cai Y, et al. Among authors: wu g. Aging (Albany NY). 2021 Mar 19;13(7):9679-9692. doi: 10.18632/aging.202716. Epub 2021 Mar 19. Aging (Albany NY). 2021. PMID: 33744868 Free PMC article.

9

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis.

Wu G, Yan Y, Cai Y, Peng B, Li J, Huang J, Xu Z, Zhou J. Wu G, et al. Front Cell Dev Biol. 2021 Jun 3;9:633927. doi: 10.3389/fcell.2021.633927. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34150745 Free PMC article.

10

A combined analysis of bulk and single-cell sequencing data reveals metabolic enzyme, pyruvate dehydrogenase E1 subunit beta (PDHB), as a prediction biomarker for the tumor immune response and immunotherapy.

Zhang F, Yan Y, Liang Q, Liu Y, Wu G, Xu Z, Yang K. Zhang F, et al. Among authors: wu g. Heliyon. 2023 Feb 7;9(2):e13456. doi: 10.1016/j.heliyon.2023.e13456. eCollection 2023 Feb. Heliyon. 2023. PMID: 36816316 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,186 results

Search Page

Filters